Laurel Wealth Advisors LLC Lowers Stake in Henry Schein, Inc. (HSIC)

Share on StockTwits

Laurel Wealth Advisors LLC trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC) by 7.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,455 shares of the company’s stock after selling 900 shares during the period. Laurel Wealth Advisors LLC’s holdings in Henry Schein were worth $628,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Mission Wealth Management LP grew its position in Henry Schein by 4.4% in the 4th quarter. Mission Wealth Management LP now owns 4,329 shares of the company’s stock valued at $340,000 after buying an additional 182 shares during the last quarter. Wilbanks Smith & Thomas Asset Management LLC grew its position in Henry Schein by 5.9% in the 4th quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 3,368 shares of the company’s stock valued at $264,000 after buying an additional 189 shares during the last quarter. CWM Advisors LLC grew its position in Henry Schein by 5.6% in the 4th quarter. CWM Advisors LLC now owns 3,678 shares of the company’s stock valued at $289,000 after buying an additional 196 shares during the last quarter. Piedmont Investment Advisors Inc. grew its position in Henry Schein by 5.5% in the 1st quarter. Piedmont Investment Advisors Inc. now owns 4,090 shares of the company’s stock valued at $246,000 after buying an additional 212 shares during the last quarter. Finally, Sumitomo Mitsui Asset Management Company LTD grew its position in Henry Schein by 2.2% in the 1st quarter. Sumitomo Mitsui Asset Management Company LTD now owns 10,006 shares of the company’s stock valued at $601,000 after buying an additional 215 shares during the last quarter.

HSIC has been the topic of a number of analyst reports. ValuEngine lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Tuesday, January 29th. BidaskClub lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Tuesday, January 29th. Zacks Investment Research raised Henry Schein from a “sell” rating to a “hold” rating in a report on Wednesday, January 30th. Royal Bank of Canada reduced their target price on Henry Schein to $69.00 and set a “sector perform” rating for the company in a report on Tuesday, February 12th. Finally, Craig Hallum reduced their target price on Henry Schein from $96.00 to $72.00 and set a “buy” rating for the company in a report on Tuesday, February 19th. Six equities research analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $74.27.

Henry Schein stock opened at $67.02 on Friday. Henry Schein, Inc. has a one year low of $56.58 and a one year high of $91.35. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.65 and a quick ratio of 0.93. The firm has a market capitalization of $10.27 billion, a price-to-earnings ratio of 16.23, a price-to-earnings-growth ratio of 2.41 and a beta of 0.89.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.76 by $0.04. The business had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.36 billion. Henry Schein had a return on equity of 18.35% and a net margin of 4.10%. The business’s revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.95 EPS. On average, analysts predict that Henry Schein, Inc. will post 3.45 earnings per share for the current year.

In other news, Director Philip A. Laskawy sold 1,084 shares of Henry Schein stock in a transaction on Tuesday, March 12th. The stock was sold at an average price of $59.86, for a total transaction of $64,888.24. Following the completion of the transaction, the director now owns 32,899 shares of the company’s stock, valued at approximately $1,969,334.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.06% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was originally posted by Week Herald and is owned by of Week Herald. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://weekherald.com/2019/05/26/laurel-wealth-advisors-llc-lowers-stake-in-henry-schein-inc-hsic.html.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading: What is the Current Ratio?

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.